---
# System prepended metadata

title: COVID-19 ENT Instruments Market Insights

---

# COVID-19 ENT Instruments Market Insights
![](https://i.imgur.com/7WKwAQy.jpg)


While COVID-19 had a negative influence on the ENT Instruments industry last year, 27.4 million procedures were delayed or canceled during the 12-week COVID-19 surge. Clinical processes have been slowed as a result of the COVID-19 epidemic. This may have an impact on market growth to some extent. Clinical trial delays have been recorded by leading ENT Instruments manufacturers such as Cochlear Ltd and Smith & Nephew. Cancer diagnosis or treatment was involved in 2.4 million of these cases. Cases with benign diseases, orthopedic disorders, or ENT concerns were mostly delayed or postponed.

Net revenues for the fiscal year 2021 were USD 1.3 billion as a result of Medtronic Plc's COVID-19 Specialty Therapies segment, representing a 9% decrease from 2021. COVID-19 caused a delay in surgeries in the ENT and pelvic health sectors, resulting in a decrease in net sales. Before the pandemic, the **[operative](https://gbuzzn.com/what-are-the-uses-of-ear-nose-and-throat-ent-instruments/)** NIM nerve monitoring system, powered ENT instruments, and ENT surgical navigation system machinery and equipment revenues improved the fiscal year 2020 revenues.

Medical device taxes and duties: The implementation of medical device taxes and duties are projected to influence the profitability of airway management equipment makers. This entails imposing a 2.3 percent excise fee on domestic sales of charged medical equipment in the United States beginning in March 2010. In a similar vein, the Indian government included a 5% levy on imported medical devices in its 2021 budget. According to the Medical Technological Association of India, the tariff will raise the cost of imported goods and make the country's healthcare less accessible.

# **Market Segmentation of ENT Instruments:**

In 2021, the Diagnostics **ENT Instruments** category dominated the market with a 31% share. The diagnostic ENT devices section includes flexible endoscopes, robot-assisted endoscopes, hearing screening devices, and rigid [endoscopes](https://nboxoffice.com/what-are-these-ent-instruments/). The availability of technologically advanced endoscopes has increased the demand for diagnostic ENT equipment. These endoscopes are more adaptable and efficient than more traditional diagnostic equipment. As a result, doctors' expectations for affordable, precise, and effective diagnoses have skyrocketed.

In terms of end-user, hospitals dominated the market with a 39% share in 2021. Hospitals are the principal treatment facilities in the international healthcare system. Hospitals play an important role in the delivery of ENT treatment. In developing countries, hospitals are sometimes the only places where ENT surgery can be performed. Increased disposable income, reduced ENT treatment prices, improved healthcare expenditure and infrastructure, and higher understanding and awareness of ENT operations internationally are driving the market.

ENT clinics are the second-largest market end-users of ENT equipment. This is because clinics are regularly used to diagnose and treat ENT diseases. In emerging nations, ENT **[clinics](https://www.tbusinessweek.com/what-does-a-disposable-vaginal-speculum-do/)** are usually equipped with hearing diagnostic instruments.

# **Market Regional Insights from ENT:**

In 2021, North America will hold a 37% share of the market. Increased adoption of cutting-edge technologies is likely to boost market expansion in this region. Furthermore, wealthy countries are significantly more aware of the significance of ENT diseases, as well as the **[availability](https://dribbble.com/shots/20961139-Several-Types-of-Hemostatic-Forceps?added_first_shot=true)** of therapies and equipment to lessen their impacts. In the United States, between 500,000 and 65,000 new instances of Ménière's disease are diagnosed each year. It is a disease of the inner ear that causes vertigo and hearing loss. Market statistics will also be influenced by favorable trade policies, ENT device laws, and a strong presence of significant market participants in the region.

Throughout the projection period, the Asia Pacific region is expected to increase at a CAGR of 7.3%. This is due to earlier detection of ENT-related disorders, higher healthcare cost, and increased market participants' investment. Europe has risen to second place in this market. Because of the region's developed healthcare system, high levels of patient knowledge, and high hearing aid product penetration.

The report's goal is to provide industry stakeholders with a complete study of the global ENT Devices Market. The research analyzes complicated data in simple language and presents the past and current state of the industry, as well as anticipated market size and trends.

The research includes a PORTER and PESTEL analysis, as well as the possible impact of market microeconomic aspects. **[External](https://selfiewrldlasvegas.com/disposable-vaginal-speculum/)** and internal elements that are expected to affect the firm positively or negatively have been studied, providing decision-makers with a clear future vision of the industry.

The study serves as an investor's guide by providing a clear depiction of competition analysis of key players in the ENT Devices Market by product, price, financial condition, product portfolio, growth plans, and regional presence.


